Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference newsletter

  Cervical Cancer

  Free Subscription


1 Am J Obstet Gynecol
1 Am J Prev Med
1 Ann Clin Lab Sci
1 Ann Surg Oncol
1 Ann Thorac Med
1 Asian Pac J Cancer Prev
1 Biochem Cell Biol
1 Biomark Med
1 Biomed Res Int
1 Biomed Tech (Berl)
1 BMC Cancer
1 BMC Public Health
1 BMC Womens Health
1 Cancer Causes Control
1 Cancer Cell Int
2 Cancer Cytopathol
1 Cancer Epidemiol
1 Cancer Lett
1 Cell Cycle
2 Cell Death Dis
1 Dis Markers
1 Evid Based Complement Alternat Med
1 Exp Cell Res
1 Front Cell Dev Biol
2 Front Oncol
1 Genomics
3 Gynecol Oncol
1 Int J Clin Oncol
1 Int J Gynecol Cancer
2 Int J Mol Sci
1 Int J Radiat Oncol Biol Phys
1 Int Q Community Health Educ
1 Int Rev Immunol
1 J Am Soc Cytopathol
1 J Comput Assist Tomogr
1 J Magn Reson Imaging
1 J Med Microbiol
1 J Oncol
1 JNMA J Nepal Med Assoc
1 Medicina (Kaunas)
1 Mol Cancer Ther
1 Mol Cell Biochem
1 Nanotechnology
1 Nat Commun
1 Pan Afr Med J
1 Pathogens
6 PLoS One
1 Radiat Res
1 Reprod Health
2 Sci Rep
9 Semin Radiat Oncol
1 Stat Med
1 Technol Cancer Res Treat
1 Turk J Obstet Gynecol
1 Vaccine
2 West Afr J Med
1 Women Health

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Obstet Gynecol

  1. CHIDO-AMAJUOYI OG, Talluri R, Shete S
    Prevalence of Abnormal Cervical Cancer Screening Outcomes among Women in the United States: Results from the National Health Interview Survey, 2018.
    Am J Obstet Gynecol. 2020 Aug 21. pii: S0002-9378(20)30878.

    Am J Prev Med

  2. DONLEY T, Tshiswaka DI, Blanc J, Seixas A, et al
    Differences in Breast and Cervical Cancer Screening Among U.S. Women by Nativity and Family History.
    Am J Prev Med. 2020 Aug 20. pii: S0749-3797(20)30268.
    PubMed         Abstract available

    Ann Clin Lab Sci

  3. DUAN W, Liu X
    PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
    Ann Clin Lab Sci. 2020;50:512-518.
    PubMed         Abstract available

    Ann Surg Oncol

  4. ZANAGNOLO V, Aloisi A
    ASO Author Reflections: Robotic Radical Hysterectomy for Patients with Early-Stage Cervical Cancer: Oncologic Outcomes.
    Ann Surg Oncol. 2020 Aug 26. pii: 10.1245/s10434-020-09057.

    Ann Thorac Med

    Smoking in users of a cervical cancer screening center of the Mexican government at Mexico City.
    Ann Thorac Med. 2020;15:180-181.

    Asian Pac J Cancer Prev

  6. DSOUZA JP, Van Den Broucke S, Pattanshetty S, Dhoore W, et al
    Exploring the Barriers to Cervical Cancer Screening through the Lens of Implementers and Beneficiaries of the National Screening Program: A Multi-Contextual Study.
    Asian Pac J Cancer Prev. 2020;21:2209-2215.
    PubMed         Abstract available

    Biochem Cell Biol

  7. ZHANG Y, Jiang L, Qin N, Cao M, et al
    hCINAP is a potential direct HIF-1 target gene and is required for hypoxia-induced EMT and apoptosis in cervical cancer cells.
    Biochem Cell Biol. 2020 Aug 23. doi: 10.1139/bcb-2020-0090.
    PubMed         Abstract available

    Biomark Med

  8. ZACAPALA-GOMEZ AE, C Alarcon-Romero LD, Mendoza-Catalan MA, Salmeron-Barcenas EG, et al
    Integrin subunit beta1 and laminin gamma1 chain expression: a potential prognostic biomarker in cervical cancer.
    Biomark Med. 2020 Aug 26. doi: 10.2217/bmm-2020-0140.
    PubMed         Abstract available

    Biomed Res Int

  9. WANG Y, Zhang Z, Tao P, Reyila M, et al
    The Abnormal Expression of miR-205-5p, miR-195-5p, and VEGF-A in Human Cervical Cancer Is Related to the Treatment of Venous Thromboembolism.
    Biomed Res Int. 2020;2020:3929435.
    PubMed         Abstract available

    Biomed Tech (Berl)

  10. KONSTANDINOU C, Kostopoulos S, Glotsos D, Pappa D, et al
    GPU-enabled design of an adaptable pattern recognition system for discriminating squamous intraepithelial lesions of the cervix.
    Biomed Tech (Berl). 2020;65:315-325.
    PubMed         Abstract available


    Better triage tests needed for HPV-positive women.
    BJOG. 2020;127:1268.

    BMC Cancer

  12. ZHAO D, Zhang L, Xie F, Peng D, et al
    Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    BMC Cancer. 2020;20:810.
    PubMed         Abstract available

    BMC Public Health

  13. LOTT BE, Trejo MJ, Baum C, McClelland DJ, et al
    Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model.
    BMC Public Health. 2020;20:654.
    PubMed         Abstract available

    BMC Womens Health

  14. PAPALIA N, Rohla A, Tang S, Nation J, et al
    Defining the short-term disease recurrence after loop electrosurgical excision procedure (LEEP).
    BMC Womens Health. 2020;20:34.
    PubMed         Abstract available

    Cancer Causes Control

  15. ATERE-ROBERTS J, Smith JL, Hall IJ
    Interventions to increase breast and cervical cancer screening uptake among rural women: a scoping review.
    Cancer Causes Control. 2020 Aug 25. pii: 10.1007/s10552-020-01340.
    PubMed         Abstract available

    Cancer Cell Int

  16. YANG S, Jiang Y, Ren X, Feng D, et al
    FOXA1-induced circOSBPL10 potentiates cervical cancer cell proliferation and migration through miR-1179/UBE2Q1 axis.
    Cancer Cell Int. 2020;20:389.
    PubMed         Abstract available

    Cancer Cytopathol

  17. NELSON B
    Cervical and anal cancer prevention in jails and prisons: "A missed opportunity": Although cancers linked to the human papillomavirus are preventable through vaccination and screening, these protective measures largely have been overlooked in correcti
    Cancer Cytopathol. 2020;128:227-228.

  18. PANTANOWITZ L, Pantanowitz J, Escalante EP, Krotish D, et al
    Volunteering at CerviCusco in Peru.
    Cancer Cytopathol. 2020;128:155-157.

    Cancer Epidemiol

  19. OLIVEIRA NPD, Santos Siqueira CAD, Lima KYN, de Camargo Cancela M, et al
    Association of cervical and breast cancer mortality with socioeconomic indicators and availability of health services.
    Cancer Epidemiol. 2020;64:101660.
    PubMed         Abstract available

    Cancer Lett

  20. SUN Y, Yang X, Liu M, Tang H, et al
    Corrigendum to "B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells." [Canc. Lett. 375 (2016) 284-292].
    Cancer Lett. 2020;493:16-18.

    Cell Cycle

  21. HE Q, Meng J, Liu S, Zeng Q, et al
    Long non-coding RNA UCA1 upregulates KIF20A expression to promote cell proliferation and invasion via sponging miR-204 in cervical cancer.
    Cell Cycle. 2020 Aug 23:1-10. doi: 10.1080/15384101.2020.1807666.
    PubMed         Abstract available

    Cell Death Dis

  22. LIU P, Zhang C, Liao Y, Liu J, et al
    High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.
    Cell Death Dis. 2020;11:687.
    PubMed         Abstract available

  23. LIU X, Song J, Zhang Y, Wang H, et al
    ASF1B promotes cervical cancer progression through stabilization of CDK9.
    Cell Death Dis. 2020;11:705.
    PubMed         Abstract available

    Dis Markers

  24. MA X, Xue H, Zhong J, Feng B, et al
    Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.
    Dis Markers. 2020;2020:5327378.
    PubMed         Abstract available

    Evid Based Complement Alternat Med

  25. LIU S, Yan H, Liu Y, Tang Y, et al
    Zhidai Decoction Inhibits Cervical Cancer through Regulation of Vaginal Microbiota.
    Evid Based Complement Alternat Med. 2020;2020:8940582.
    PubMed         Abstract available

    Exp Cell Res

  26. YANG F, Li L, Zhang J, Zhang J, et al
    TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
    Exp Cell Res. 2020 Aug 24:112248. doi: 10.1016/j.yexcr.2020.112248.
    PubMed         Abstract available


  27. OU R, Lv M, Liu X, Lv J, et al
    HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
    FASEB J. 2020 Aug 26. doi: 10.1096/fj.202000762.
    PubMed         Abstract available

    Front Cell Dev Biol

  28. NI G, Chen S, Chen M, Wu J, et al
    Host-Defense Peptides Caerin 1.1 and 1.9 Stimulate TNF-Alpha-Dependent Apoptotic Signals in Human Cervical Cancer HeLa Cells.
    Front Cell Dev Biol. 2020;8:676.
    PubMed         Abstract available

    Front Oncol

  29. ZHU B, Wu Y, Luo J, Zhang Q, et al
    MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21(cip1).
    Front Oncol. 2020;10:1307.
    PubMed         Abstract available

  30. XIE L, Chu R, Wang K, Zhang X, et al
    Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach.
    Front Oncol. 2020;10:1353.
    PubMed         Abstract available


  31. ROYCHOWDHURY A, Samadder S, Das P, Mazumder DI, et al
    Deregulation of H19 is associated with cervical carcinoma.
    Genomics. 2020;112:961-970.
    PubMed         Abstract available

    Gynecol Oncol

  32. GURRAM L, Patil R, Chopra S, Maheshwari A, et al
    Evaluation of outcomes in patients of cervical Cancer with lower one third vaginal involvement: A single institutional experience.
    Gynecol Oncol. 2020 Aug 20. pii: S0090-8258(20)33809.
    PubMed         Abstract available

  33. OHNO A, Iwata T, Katoh Y, Taniguchi S, et al
    Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Gynecol Oncol. 2020 Aug 20. pii: S0090-8258(20)33756.
    PubMed         Abstract available

  34. MAULARD A, Chargari C, Faron M, Alwohaibi A, et al
    A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer.
    Gynecol Oncol. 2020 Aug 19. pii: S0090-8258(20)33758.
    PubMed         Abstract available

    Int J Clin Oncol

  35. KUSADA T, Toita T, Ariga T, Kudaka W, et al
    Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
    Int J Clin Oncol. 2020 Aug 27. pii: 10.1007/s10147-020-01736.
    PubMed         Abstract available

    Int J Gynecol Cancer

  36. CIAVATTINI A, Delli Carpini G, Giannella L, Arbyn M, et al
    European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.
    Int J Gynecol Cancer. 2020;30:1097-1100.

    Int J Mol Sci

  37. YI SA, Kim GW, Yoo J, Han JW, et al
    HP1gamma Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available

  38. SIXTO-LOPEZ Y, Rosales-Hernandez MC, Contis-Montes de Oca A, Fragoso-Morales LG, et al
    N-(2'-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  39. VITTRUP AS, Tanderup K, Bentzen SM, Jensen NBK, et al
    Persistence of late substantial patient-reported symptoms (LAPERS) after radiochemotherapy including image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
    Int J Radiat Oncol Biol Phys. 2020 Aug 24. pii: S0360-3016(20)34139.
    PubMed         Abstract available

    Int Q Community Health Educ

  40. Corrigendum to Increasing Human Papillomavirus Vaccination and Cervical Cancer Screening in Nigeria: An Assessment of Community-Based Educational Interventions.
    Int Q Community Health Educ. 2020 Aug 27:272684X20956556.

    Int Rev Immunol

  41. JEE B, Yadav R, Pankaj S, Shahi SK, et al
    Immunology of HPV-mediated cervical cancer: current understanding.
    Int Rev Immunol. 2020 Aug 27:1-20. doi: 10.1080/08830185.2020.1811859.
    PubMed         Abstract available

    J Am Soc Cytopathol

  42. AUSTIN RM, Onisko A, Zhao C
    Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
    J Am Soc Cytopathol. 2020 Jul 29. pii: S2213-2945(20)30262.

    J Comput Assist Tomogr

  43. ZHANG X, Dong Y, Song Q, Zhu Y, et al
    The Role of Multiparametric Magnetic Resonance Imaging in the Study of Primary Tumor and Pelvic Lymph Node Metastasis in Stage IB1-IIA1 Cervical Cancer.
    J Comput Assist Tomogr. 2020 Aug 24. doi: 10.1097/RCT.0000000000001084.
    PubMed         Abstract available

    J Magn Reson Imaging

    Editorial for: "Novel T2 Mapping for Evaluating Cervical Cancer Features by Providing Quantitative T2 Maps and Synthetic Morphologic Images: A Preliminary Study".
    J Magn Reson Imaging. 2020 Aug 23:e27296. doi: 10.1002/jmri.27296.

    J Med Microbiol

  45. TREVISAN A, Candeias JMG, Thomann P, Villa LL, et al
    Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    J Med Microbiol. 2020 Jun 8. doi: 10.1099/jmm.0.001213.
    PubMed         Abstract available

    J Oncol

  46. SENCHUKOVA MA, Makarova EV, Shurygina EI, Volchenko NN, et al
    Morphological Characteristics and Clinical Significance of Different Types of Tumor Vessels in Patients with Stages I-IIA of Squamous Cervical Cancer.
    J Oncol. 2020;2020:3818051.
    PubMed         Abstract available

    JNMA J Nepal Med Assoc

  47. PARAJULI G, Dawadi P, Khadka S
    Prevalence of Cervical Cancer among Cervical Biopsies in a Tertiary Care Center.
    JNMA J Nepal Med Assoc. 2020;58:453-455.
    PubMed         Abstract available

    Medicina (Kaunas)

  48. RANCIC NK, Golubovic MB, Ilic MV, Ignjatovic AS, et al
    Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia.
    Medicina (Kaunas). 2020;56.
    PubMed         Abstract available

    Mol Cancer Ther

  49. TEWARI KS, Sill MW, Monk BJ, Penson RT, et al
    Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology - Gynecologic Oncology Group Study 240 (NCT 00803062).
    Mol Cancer Ther. 2020 Aug 26. pii: 1535-7163.MCT-20-0276.
    PubMed         Abstract available

    Mol Cell Biochem

  50. ZHANG W, Xue F, Xie S, Chen C, et al
    Isoflurane promotes proliferation of squamous cervical cancer cells through mTOR-histone deacetylase 6 pathway.
    Mol Cell Biochem. 2020 Aug 24. pii: 10.1007/s11010-020-03884.
    PubMed         Abstract available


  51. LIN X, Cao Y, Xue Y, Wu F, et al
    Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment.
    Nanotechnology. 2020;31:135101.
    PubMed         Abstract available

    Nat Commun

  52. LI Z, Peng Y, Li J, Chen Z, et al
    N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4.
    Nat Commun. 2020;11:2578.
    PubMed         Abstract available

    Pan Afr Med J

  53. AKINLEYE HW, Kanma-Okafor OJ, Okafor IP, Odeyemi KA, et al
    Parental willingness to vaccinate adolescent daughters against human papilloma virus for cervical cancer prevention in Western Nigeria.
    Pan Afr Med J. 2020;36:112.
    PubMed         Abstract available


  54. BLANCO R, Carrillo-Beltran D, Osorio JC, Calaf GM, et al
    Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Cervical Cancer: Epidemiology, Mechanisms and Perspectives.
    Pathogens. 2020;9.
    PubMed         Abstract available

    PLoS One

  55. WEEGAR R, Sundstrom K
    Using machine learning for predicting cervical cancer from Swedish electronic health records by mining hierarchical representations.
    PLoS One. 2020;15:e0237911.
    PubMed         Abstract available

  56. ARRIVILLAGA M, Bermudez PC, Garcia-Cifuentes JP, Botero J, et al
    Innovative prototypes for cervical cancer prevention in low-income primary care settings: A human-centered design approach.
    PLoS One. 2020;15:e0238099.
    PubMed         Abstract available

  57. IBANEZ R, Roura E, Monfil L, Rodriguez LA, et al
    Long-term protection of HPV test in women at risk of cervical cancer.
    PLoS One. 2020;15:e0237988.
    PubMed         Abstract available

  58. BUTLER TL, Anderson K, Condon JR, Garvey G, et al
    Indigenous Australian women's experiences of participation in cervical screening.
    PLoS One. 2020;15:e0234536.
    PubMed         Abstract available

  59. SONG F, Du H, Wang C, Huang X, et al
    The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    PLoS One. 2020;15:e0234518.
    PubMed         Abstract available

  60. HILLMAN RT, Cardnell R, Fujimoto J, Lee WC, et al
    Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
    PLoS One. 2020;15:e0234505.
    PubMed         Abstract available

    Radiat Res

  61. AMENDOLA BE, Perez NC, Mayr NA, Wu X, et al
    Spatially Fractionated Radiation Therapy Using Lattice Radiation in Far-advanced Bulky Cervical Cancer: A Clinical and Molecular Imaging and Outcome Study.
    Radiat Res. 2020 Aug 27. pii: 442749. doi: 10.1667/RADE-20-00038.
    PubMed         Abstract available

    Reprod Health

  62. MENENDEZ YA, Cambaco O, Mindu C, Nhantumbo H, et al
    Lay knowledge of cervical cancer in Manhica district, Mozambique: a qualitative study.
    Reprod Health. 2020;17:130.
    PubMed         Abstract available

    Sci Rep

  63. CASTRO-OROPEZA R, Vazquez-Santillan K, Diaz-Gastelum C, Melendez-Zajgla J, et al
    Adipose-derived mesenchymal stem cells promote the malignant phenotype of cervical cancer.
    Sci Rep. 2020;10:14205.
    PubMed         Abstract available

  64. NIE H, Bu F, Xu J, Li T, et al
    29 immune-related genes pairs signature predict the prognosis of cervical cancer patients.
    Sci Rep. 2020;10:14152.
    PubMed         Abstract available

    Semin Radiat Oncol

  65. YUSUFALY TI, Meyers SM, Mell LK, Moore KL, et al
    Knowledge-Based Planning for Intact Cervical Cancer.
    Semin Radiat Oncol. 2020;30:328-339.
    PubMed         Abstract available

  66. GURRAM L, Kalra B, Mahantshetty U
    Meeting the Global Need for Radiation Therapy in Cervical Cancer-An Overview.
    Semin Radiat Oncol. 2020;30:348-354.
    PubMed         Abstract available

  67. TANDERUP K, Nesvacil N, Kirchheiner K, Serban M, et al
    Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer.
    Semin Radiat Oncol. 2020;30:311-327.
    PubMed         Abstract available

  68. ELLEDGE CR, LaVigne AW, Bhatia RK, Viswanathan AN, et al
    Aiming for 100% Local Control in Locally Advanced Cervical Cancer: The Role of Complex Brachytherapy Applicators and Intraprocedural Imaging.
    Semin Radiat Oncol. 2020;30:300-310.
    PubMed         Abstract available

  69. RHEE DJ, Jhingran A, Kisling K, Cardenas C, et al
    Automated Radiation Treatment Planning for Cervical Cancer.
    Semin Radiat Oncol. 2020;30:340-347.
    PubMed         Abstract available

  70. SCHERNBERG A, Kumar T, Achkar S, Espenel S, et al
    Incorporating Magnetic Resonance Imaging (MRI) Based Radiation Therapy Response Prediction into Clinical Practice for Locally Advanced Cervical Cancer Patients.
    Semin Radiat Oncol. 2020;30:291-299.
    PubMed         Abstract available

  71. FENG CH, Mell LK, Sharabi AB, McHale M, et al
    Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer.
    Semin Radiat Oncol. 2020;30:273-280.
    PubMed         Abstract available

  72. SIMS TT, Klopp AH
    Intensified Systemic Therapy Regimens in Combination With Definitive Radiation for Treatment of Cervical Cancer.
    Semin Radiat Oncol. 2020;30:265-272.
    PubMed         Abstract available

  73. KLOPP AH
    Introduction: Cervical Cancer.
    Semin Radiat Oncol. 2020;30:263-264.

    Stat Med

  74. SOPER BC, Nygard M, Abdulla G, Meng R, et al
    A hidden Markov model for population-level cervical cancer screening data.
    Stat Med. 2020 Aug 27. doi: 10.1002/sim.8681.
    PubMed         Abstract available

    Technol Cancer Res Treat

  75. YANG X, Feng KX, Li H, Wang L, et al
    MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Technol Cancer Res Treat. 2020;19:1533033820942245.
    PubMed         Abstract available

    Turk J Obstet Gynecol

  76. ERCELEP O, Tataroglu D, Ozcelik M, Surmeli H, et al
    Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer.
    Turk J Obstet Gynecol. 2020;17:123-127.
    PubMed         Abstract available


  77. LIM ASE, Lim RBT
    Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26years old in Singapore: A qualitative study.
    Vaccine. 2019 Aug 28. pii: S0264-410X(19)31127.
    PubMed         Abstract available

    West Afr J Med

  78. UMAR UA, Zakari M
    Cervical Screening: Current Challenges and Prospect.
    West Afr J Med. 2020;37:326.
    PubMed         Abstract available

  79. MASEKO TN, Hui-Chuan H, Kuan-Chia L
    Factors Related to Cervical Cancer Screening Experience among Women Aged 15 and above in Eswatini: The World Health Organisation STEP's Data 2014:A Household Cross Sectional Survey.
    West Afr J Med. 2020;37:355-361.
    PubMed         Abstract available

    Women Health

  80. WANG LD, Lam WWT, Fielding R
    Development and pre/post testing of a decision aid supporting Chinese parental and young women's HPV vaccination decision-making.
    Women Health. 2020;60:330-340.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.